Forbes September 11, 2024
Plus: Recursion’s CEO talks clinical trial data for AI-designed drug
Two former Verily executives, Amy Abernathy and Brad Hirsch, announced this week that they’ve launched a new venture, Highlander Health. The organization will have two separate arms: Highlander Health Partners, which will invest in mid-stage healthcare startups, and the Highlander Health Institute, which will provide grants and mobilize partnerships with a goal of both accelerating clinical trials and utilizing real-world data to learn more about the effectiveness of different types of treatments.
“Our overarching vision is really smoothing the path towards personalized healthcare for all,” Abernathy told Forbes. “And we see that one of the critical gates on that path is in clinical evidence generation.”
The way Highlander will do...
Today's Sponsors
Today's Sponsor